Scheduled for unilateral or bilateral immediate implant-based breast reconstruction
Therapeutic or prophylactic indication
Patient understands the study procedures and objectives and is willing to participate
Patient willing to and capable of providing informed consent
You may not be if
Delayed breast reconstruction
Allergy or contraindication to local anesthetics (PVB or PECS blocks)
History of radiation therapy
Planned sedation or general anesthesia protocol variation
Morbid obesity as defined as a BMI greater than 40 kg/m2
Renal insufficiency
Chronic pain syndrome or central sensitization disorders (e.g., fibromyalgia, CRPS)
Use of implanted pain devices or neuromodulators
Pre-existing neurological deficits in the surgical field
Current chronic opioid use (daily use within the 2 weeks before surgery and duration of use greater than 4 weeks)
Use of any nerve medications in the past 6 months, including antiepileptic medications (gabapentin, carbamazepine)
History of drug or alcohol abuse or habitual alcohol intake greater than two standard drinks per day (e.g., two beers, two glasses of wine, or two mixed drinks)
Any comorbidity that results in moderate or severe functional limitation, inability to communicate with the investigators or hospital staff
History of a psychiatric disorder which would interfere with the study procedure
Incarceration
Any issue that at the discretion of the investigator would contraindicate the subject's participation
Inability to understand the procedures and objectives of the study
Inability to or unwilling to provide informed consent
Clareo Health | Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
